newsfilter
← Latest News
PR Newswire·

Oncopeptides submits application for conditional marketing authorization of melflufen in the EU

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat...